Clinical Trial Update: A Phase II, 5-way Cross-over Study to Evaluate the Pharmacodynamics of "Nexthaler" Dry Powder Inhaler in COPD Patients [Phase 2]

View source ↗

Summary

Phase II cross-over trial evaluating pharmacodynamics of Nexthaler dry powder inhaler in COPD patients, completed.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Chronic Obstructive Pulmonary Disease

Drugs mentioned

• NEXThaler

Snippet

Sponsor: Chiesi Farmaceutici S.p.A. | Conditions: COPD | Phase 2 | Status: COMPLETED